Advertise here
Advertise here

Governing global health with a planetary mindset

In 2023, six out of nine planetary boundaries were crossed, posing a threat to Earth’s stability due to disease outbreaks like Ebola, Zika, and Covid-19. The interconnection between planetary and human health requires urgent integration. While progress has been made in recognizing this link, critical gaps in joint action, political commitment, and governance hinder meaningful…

Read More

Q&A With NIH Dermatology Consultation Service Director

Dr. Edward W. Cowen is a senior clinician at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, leading multiple initiatives related to dermatology at the National Institutes of Health (NIH). He is an expert in cutaneous graft vs host disease and has made significant contributions to the field through his research. Dr. Cowen…

Read More

Bristol Myers Squibb’s Sotyktu Meets Goals in Two Pivotal Psoriatic Arthritis Studies

Bristol Myers Squibb’s drug Sotyktu, originally approved for plaque psoriasis, has shown positive results in two pivotal tests for psoriatic arthritis. Expanding approval to include this condition could increase revenue for the drug. Sotykut targets the enzyme TYK2, offering patients an alternative treatment option with potentially better safety than other Janus kinase (JAK) inhibitors. The…

Read More

Healio revisits a year in orthopedic sports medicine

Healio highlights the most-read research, topics, and news in orthopedic sports medicine in 2024. Some key points include the projected increase in orthopedic-related sports injuries in patients aged at least 65 years by 2040, a decline in sports participation and physical activity from middle school to high school, the benefits of ACL reconstruction augmentation, and…

Read More

STAT looks at AI denials, market dominance

The killing of UnitedHealthcare CEO Brian Thompson has brought attention to the health insurance industry, with criticism focused on executives prioritizing profits over customer health. STAT journalists have investigated UnitedHealth Group’s impact on American health for two years, revealing how the company leveraged its physician empire for profit and used AI algorithms to deny care….

Read More

The rapid rise of the UK’s cancer vaccine trials

The feature article discusses mRNA technology in vaccines, excluding the mention of Provenge as it is not an mRNA vaccine for prostate cancer. The article delves into the advancements of mRNA vaccines, their potential impact on healthcare, and current challenges. Significant progress has been made with mRNA vaccines, especially during the COVID-19 pandemic. The article…

Read More

12 questions to ask for better brain health in 2024

Improving brain health in the new year can start with a discussion with your neurologist or primary care physician about 12 factors outlined in an article developed by the American Academy of Neurology. These factors include sleep, mental health, diet, exercise, social interactions, trauma avoidance, blood pressure, genetic factors, affordability, infection, negative exposures, and social…

Read More

FDA Approves Second Generic Daily GLP-1 Drug for T2D

The FDA has approved a generic version of the GLP-1 RA liraglutide for people with type 2 diabetes to lower blood sugar. This follows the approval of a generic version of exenatide last month to improve access to GLP-1 medications due to shortages. The FDA supports the development of generic drugs, including GLP-1s, to increase…

Read More

Healthcare Leaders Slam Exclusion of Key Healthcare Provisions in Spending Package

President Biden signed a new spending bill that excluded key healthcare provisions, including drug pricing and prior authorization reforms. The excluded provisions would have limited the number of patents pharmaceutical companies can apply to biologics, clarified ingredient differences in generic drugs, and disconnected pharmacy benefit managers’ revenue from drug prices in Medicare Part D. Advocacy…

Read More

‘Waiting List to Nowhere’: Homelessness Surveys Trap Black Men on the Streets

Maurice Clark, a homeless man in Las Vegas, felt uncomfortable answering personal questions from outreach workers to determine housing eligibility, citing concerns about systemic racism. Vulnerability questionnaires used to prioritize housing placements have been criticized for favoring white people and exacerbating racial disparities in homelessness. Some experts are calling for a reevaluation of these assessment…

Read More

What can fecal proteins reveal about heart health?

A study from Monash University suggests that human and microbial proteins found in feces could indicate a long-term risk for cardiovascular conditions. This non-invasive method could potentially replace costly and invasive diagnostic procedures. Using a new method called metaproteomics, researchers identified proteins in fecal samples that could predict the risk of heart attack or stroke,…

Read More

New method detects human fecal contamination in water

The presence of human waste in water bodies poses a significant public health risk, requiring continuous testing for fecal contamination. Current methods rely on fecal indicator bacteria (FIB) but are limited in detecting low-level contamination and determining sources. Microbial source tracking (MST) using CrAss-like phages (CLPs) shows promise in overcoming these challenges. A new study…

Read More

How Large Language Models (LLMs) Will Revolutionize Healthcare Administration

Between 1975 and 2010, the healthcare industry saw a significant increase in healthcare administrators compared to physicians, attributed to factors such as consolidation, regulations, and technology adoption. The future of healthcare administration is projected to see continued growth due to factors like an aging population and increased data volumes. Large language models (LLMs) are being…

Read More

why am I depressed before my period?| Medical News Bulletin

Researchers have identified specific brain pathways in the medial preoptic area that are responsible for premenstrual depression-like symptoms in mice. These GABAergic neurons, which regulate mood, become less active when estrogen levels drop, leading to depressive behaviors. By studying the impact of hormone fluctuations on mood in female mice and mapping the brain circuitry involved,…

Read More

Top nephrology meeting news in 2024

US dialysis facility closures from 2018 to 2023 have raised concerns about access to vital care, especially in rural communities. Despite an increase in adults diagnosed with end-stage renal disease, there has been a decrease in facility openings. Additionally, a study found that clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta…

Read More

UnitedHealth Group: Is it time to break up health care’s colossus?

UnitedHealth Group, the largest physician empire in the United States, faces calls from Democratic lawmakers to address its monopolistic practices. Lawmakers argue that the company’s size and influence are undermining competition, corrupting Medicare, and harming patients. There are calls for a possible breakup of the business empire to restore public confidence in the healthcare system….

Read More

Soaring Pacemaker Demand Spurs Controversial New Approach

A husband sought to donate his deceased wife’s pacemaker for reuse, leading doctors at the University of Michigan to explore the idea. They established Project My Heart Your Heart, refurbishing and redistributing pacemakers to impoverished nations with high cardiovascular disease burdens. A clinical trial comparing new and refurbished devices showed promising results with no significant…

Read More

FDA approves acellular tissue engineered vessel as conduit for extremity arterial injuries

Symvess, a sterile, cell-free tissue engineered vessel made of human extracellular matrix proteins, has been approved by the FDA as a vascular conduit for extremity arterial injuries in adults. In a study of 54 patients, 67% retained primary patency and 72% retained secondary patency after treatment with Symvess. The product received priority review and regenerative…

Read More

STAT Morning Rounds: FDA “healthy” food definition

The author is leaving Morning Rounds to start a new AI newsletter called AI Prognosis. The FDA has updated its definition of “healthy” food to include foods like salmon, nuts, seeds, and certain oils. There are discrepancies in counting maternal mortality rates in the U.S., and experts emphasize the need to focus on prevention. House…

Read More

Sunglasses don’t just look good—they’re good for you, too—here’s how to choose the right pair

Australians are exposed to high levels of solar UV radiation, which can have short-term and long-term effects on the eyes and skin. Sunglasses are important for protecting our eyes from UV damage, as excessive exposure can lead to conditions like photokeratitis, cataracts, and skin cancers. Choosing the right pair of sunglasses is crucial, with categories…

Read More

Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM

Dexcom has integrated generative AI into its Stelo continuous glucose monitor, making it the first medical device company to do so. The AI platform analyzes data from the biosensor, meal logging, and other wearable technologies to provide personalized insights and recommendations for users. The AI capabilities are powered by Google Cloud’s AI models, enabling Dexcom…

Read More

Makary, Ionis, CagriSema news updates

Sign up for the biotech newsletter to stay informed about the latest developments in science and politics driving the biotech industry. This morning, Novo Nordisk’s CagriSema results disappointed investors, leading to a significant drop in their stock value. Ionis Pharmaceuticals received FDA approval for their rare disease therapy, marking a strategic shift towards independent commercialization….

Read More

Coronary artery disease common in patients with cirrhosis

Coronary artery disease (CAD) is prevalent in patients with cirrhosis, but cirrhosis itself does not significantly increase the risk of CAD, according to a study published in the Journal of Clinical and Translational Hepatology. Through a review of 51 studies, researchers found that CAD, acute coronary syndromes, and myocardial infarction (MI) incidences were relatively low…

Read More

Insulin degradation uncovered as a new driver of resistance

A recent study published in NPJ Metabolic Health and Disease suggests that the degradation of endogenously secreted insulin, termed ‘chain-splitting,’ is a key mechanism underlying insulin resistance. The study challenges the commonly held belief that insulin receptor signaling defects are responsible for insulin resistance. Researchers demonstrate that chain-splitting of human insulin chains A and B…

Read More

Is Whole Blood Making a Comeback to Civilian Practice?

A clinical trial in Finland is exploring the use of whole blood for transfusions by emergency services before patients reach the hospital, in an effort to improve outcomes for patients with acute bleeding. Previous trials in the UK and France have suggested that whole blood may be a viable replacement for current blood products in…

Read More

5 Key Tech Innovations Transforming Clinical Research

The clinical research field is undergoing significant technological advancements that are reshaping how studies are conducted for enhanced efficiency, accuracy, and patient-centric focus. Five major advances include advanced data analytics and artificial intelligence, wearable health devices for real-time monitoring, decentralized clinical trials, patient engagement and feedback technologies, and blockchain for secure data sharing. These technologies…

Read More

Why Walgreens Is Reportedly Considering a Private Equity Buyer

Walgreens is considering selling itself to private equity firm Sycamore Partners after years of financial struggles and a declining stock price. The sale could be worth $9.2 to $10 billion. Experts believe that selling to a private equity buyer could help the company make operational improvements and focus on high-growth segments. Sycamore Partners, despite lacking…

Read More

Healio revisits a year in knee replacement

Healio highlights key findings in total knee arthroplasty research in 2024. Vitamin D deficiency is linked to poorer outcomes post-TKA, but supplementation may help. Low-dose aspirin is effective for preventing venous thromboembolism after TKA. GLP-1 receptor agonists can benefit TKA patients without diabetes. All-polyethylene TKA components may decrease revision risk compared to metal-backed components. Robotic-assisted…

Read More
Advertise here
error: Content is protected !!